Screener
RWL vs PJP
Invesco S&P 500 Revenue ETF vs Invesco Pharmaceuticals ETF
Key differences
- RWL costs 0.18% less per year.
- RWL is significantly larger than PJP — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, RWL has delivered higher annualized returns.
Side-by-side comparison
| RWL | PJP | |
|---|---|---|
| Annual cost (TER) | 0.39% | 0.57% |
| Fund size (AUM) | $8.8B | $334M |
| Since | 2008 | 2005 |
| Dividend yield | 1.28% | 1.01% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +29.1% | +40.6% |
| CAGR 3Y | +20.2% | +14.0% |
| CAGR 5Y | +13.3% | +7.8% |
| Sharpe 3Y | 1.28 | 0.69 |
| Volatility 1Y | 10.12% | 16.23% |
| Max drawdown | -36.04% | -33.95% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to RWL and PJP
Explore further